Precision Medicine News and Research

RSS

6,000 genes help determine body weight

Reporting in the online journal BMC Genetics, researchers from the Monell Center have for the first time attempted to count the number of genes that contribute to obesity and body weight.

15 Jan 2008

Personalized medicine will alter treatment of genetic disorders

One of the nation's pre-eminent genetic researchers, Eric Hoffman, PhD, of Children's Research Institute at Children's National Medical Center, predicts that in relatively short order, medicine's next innovation--individualized molecular therapies--will have the unprecedented ability to treat muscular dystrophies, and other disorders.

28 Dec 2007

New biochip technology could eliminate animal testing in chemicals and cosmetics industries

A new biochip technology could eliminate animal testing in the chemicals and cosmetics industries, and drastically curtail its use in the development of new pharmaceuticals, according to new findings from a team of researchers at Rensselaer Polytechnic Institute, the University of California at Berkeley, and Solidus Biosciences Inc.

18 Dec 2007

New test for targeted therapy in acute myeloid leukemia

Oregon Health & Science University Cancer Institute researcher Jeff Tyner, Ph.D., has created a way to identify proteins that are candidates for targeted therapy in acute myeloid leukemia using an assay that yields results in just four days.

10 Dec 2007

Latest on research on cancer prevention

Perhaps the best way to fight cancer is to prevent it from developing in the first place.

29 Nov 2007

The science of cancer health disparities in racial/ethnic minorities and the medically underserved

The latest biological, clinical and social research behind how cancer affects different racial and ethnic groups will be the focus of the first American Association for Cancer Research conference on the topic, entitled "The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved."

21 Nov 2007

New technique enables the detection of biomolecules' dynamic reactions in a single living cell

By taking advantage of the signature frequency by which organic and inorganic molecules absorb light, the team of researchers, led by Luke Lee, professor of bioengineering and director of UC Berkeley's Biomolecular Nanotechnology Center, can determine in real time whether specific enzymes are activated or particular genes are expressed, all with unprecedented resolution within a single living cell.

19 Nov 2007

Stanford scientists find gene that gives dogs black fur

A discovery about the genetics of coat color in dogs could help explain why humans come in different weights and vary in our abilities to cope with stress, a team led by researchers from the Stanford University School of Medicine reports.

30 Oct 2007

Gene screen patent brings 2007 Deal of Distinction Award to UChicagoTech

UChicagoTech, the University of Chicago's Office of Technology and Intellectual Property, has received a 2007 Deal of Distinction Award from the Licensing Executives Society of U.S.A. and Canada.

29 Oct 2007

Public not so sure about 'personalized medicine'

Ordinary people worry about the extra, and often burdensome, responsibilities which could come with scientists' promises of 'personalised medicine', according to evidence to be presented at a major two-day showcase of groundbreaking social science research into the whole field of genomics, funded by the Economic and Social Research Council (ESRC).

25 Oct 2007

New genetic understanding of multiple sclerosis patients response to Copaxone

A group of Israeli scientists from the Technion - Israel Institute of Technology, the Weizmann Institute of Science, and Teva Pharmaceutical Industries have recently identified genes responsible for the positive response of many multiple sclerosis (MS) patients to the drug Copaxone.

11 Oct 2007

Vanda Pharmaceuticals submits iloperidone NDA

Vanda Pharmaceuticals has announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for iloperidone, an investigational atypical antipsychotic for the treatment of schizophrenia.

27 Sep 2007

BioNanomatrix issued new nanofluidics patent

The patent covers a novel technique for the integration of nanofluidic channels with sample delivery systems, enabling single molecules of DNA, RNA or other proteins to be separated out from standard laboratory samples for direct imaging and analysis.

25 Sep 2007

Why some people find it so difficult to stop smoking

Mark Twain boasted that it was easy to quit smoking because he did it every day.

24 Sep 2007

Genetic variation affects smoking cessation treatment

Mark Twain boasted that it was easy to quit smoking because he did it every day.

21 Sep 2007

DNA microarray chips improved therapy in some patients with incurable cancer

Like many oncologists, Eric P. Lester, M.D., was faced with a dilemma: seven patients with advanced, incurable cancer, an arsenal of drugs that may or may not help them, and not enough solid proof about treatment efficacy to guide him.

20 Sep 2007

Rapid test to screen blood approved by the FDA

The U.S. Food and Drug Administration (FDA) has given it's approval for the first rapid test to detect bacterial contamination in blood platelets prior to transfusion.

20 Sep 2007

Genetic lab test for Warfarin sensitivity approved by FDA

The U.S. Food and Drug Administration today cleared for marketing a new genetic test that will help physicians assess whether a patient may be especially sensitive to the blood-thinning drug warfarin (Coumadin), which is used to prevent potentially fatal clots in blood vessels.

18 Sep 2007

Maximizing opportunities for personalized treatment

Scientists and clinicians from around the world will gather in Atlanta, Georgia next week at the American Association for Cancer Research's second International Conference on Molecular Diagnostics in Cancer Therapeutic Development.

11 Sep 2007